PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 5, 2024Pakistan Journal of Medical & Health Sciences0 citations

Helicobacter Pylori and Peptic Ulcer Disease

View Full Paper
MTMuhammad S. Tahir

Key Points

  • Elimination of helicobacter pylori significantly improves outcomes for patients with peptic ulcer disease, reducing recurrence.
  • Around 50% of the global population is affected by helicobacter pylori, particularly in underdeveloped regions.
  • PAC therapy, which includes proton pump inhibitors and antibiotics, effectively eradicates helicobacter pylori.
  • Addressing lifestyle factors alongside treatment may enhance recovery, but H. pylori eradication is essential.

Abstract

Dear Editor, Peptic ulcer disease causes mucosal ulcers primarily in distal stomach and proximal duodenum, presenting as recurring pain in abdomen, bloating, and is often associated with nausea, vomiting and gastrointestinal bleed. The underlying mechanism involves a defect in mucosal protection and an increased gastric acid secretion causing the damage. Helicobacter Pylori, the use of nonsteroidal anti-inflammatory drugs, smoking and alcohol and are some of the common causative agents. H. Pylori affect about 50% of the population worldwide, especially in underdeveloped nations and is linked to chronic gastritis, B cell mucosa-associated lymphoma and gastric carcinoma. While some etiologies can be managed easily by lifestyle change, elimination of H. Pylori remains essential in preventing and treating gastrointestinal diseases.PAC therapy is a standard eradication strategy which uses proton pump inhibitors in conjunction with two antibiotics for up to 7-14 days.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Muhammad S. Tahir (2024) studied this question.

synapsesocial.com/papers/68af658fad7bf08b1eae5028https://doi.org/10.53350/pjmhs020241878
Ask AI
Helpful
Bookmark
Share
View Full Paper